Literature DB >> 25639416

Venovenous extracorporeal membrane oxygenation as a bridge to lung transplantation: successful transplantation after 155 days of support.

Zachary N Kon1, P Brody Wehman2, Marc Gibber2, Joseph Rabin3, Charles F Evans2, Keshava Rajagopal2, Daniel Herr3, Aldo Iacono4, Jose P Garcia5, Bartley P Griffith2.   

Abstract

We present a case of a woman with acute respiratory distress syndrome and irrecoverable lung function that was successfully bridged to lung transplantation after 155 consecutive days of venovenous extracorporeal membrane oxygenation.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2015        PMID： 25639416     DOI： 10.1016/j.athoracsur.2014.04.097

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  9 in total

Review 1.  Extracorporeal membrane oxygenation in the pre and post lung transplant period.

Authors:  Nirmal S Sharma; Mathew G Hartwig; Don Hayes
Journal:  Ann Transl Med       Date:  2017-02

2.  Successful use of veno-venous extracorporeal membrane oxygenation as a bridge to lung T transplantation in a patient with pulmonary fibrosis.

Authors:  Nao Umei; Shingo Ichiba; Masayuki Chida
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-11-09

3.  Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

Authors:  Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos
Journal:  J Heart Lung Transplant       Date:  2021-07-24       Impact factor: 13.569

Review 4.  Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation.

Authors:  Mary K Porteous; Joshua M Diamond; Jason D Christie
Journal:  Curr Opin Organ Transplant       Date:  2015-10       Impact factor: 2.640

5.  Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis.

Authors:  Franziska C Trudzinski; Peter Minko; Daniel Rapp; Sebastian Fähndrich; Hendrik Haake; Myriam Haab; Rainer M Bohle; Monika Flaig; Franziska Kaestner; Robert Bals; Heinrike Wilkens; Ralf M Muellenbach; Andreas Link; Heinrich V Groesdonk; Christian Lensch; Frank Langer; Philipp M Lepper
Journal:  Ann Intensive Care       Date:  2016-07-19       Impact factor: 6.925

6.  Clinical implications of Mycobacterium chimaera detection in thermoregulatory devices used for extracorporeal membrane oxygenation (ECMO), Germany, 2015 to 2016.

Authors:  Franziska C Trudzinski; Uwe Schlotthauer; Annegret Kamp; Kai Hennemann; Ralf M Muellenbach; Udo Reischl; Barbara Gärtner; Heinrike Wilkens; Robert Bals; Mathias Herrmann; Philipp M Lepper; Sören L Becker
Journal:  Euro Surveill       Date:  2016-11-17

7.  Idiopathic pulmonary fibrosis patient supported with extracorporeal membrane oxygenation for 403 days while waiting for a lung transplant: A case report.

Authors:  Nao Umei; Shingo Ichiba; Atsuhiro Sakamoto
Journal:  Respir Med Case Rep       Date:  2018-04-26

Review 8.  Lung Transplant from ECMO: Current Results and Predictors of Post-transplant Mortality.

Authors:  Basil S Nasir; Jacob Klapper; Matthew Hartwig
Journal:  Curr Transplant Rep       Date:  2021-04-06

9.  Lung transplantation for acute respiratory distress syndrome: A multicenter experience.

Authors:  Anna E Frick; Christiaan T Gan; Robin Vos; Stefan Schwarz; Felix Kraft; Daria Kifjak; Arne P Neyrinck; Dirk E Van Raemdonck; Walter Klepetko; Peter Jaksch; Erik A M Verschuuren; Konrad Hoetzenecker
Journal:  Am J Transplant       Date:  2021-07-24       Impact factor: 9.369
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.